Lundbeck Shares AAN 2026 Data Showing Real-World Cognitive Improvements in Migraine Patients Treated with VYEPTI Lundbeck today presented new real-world 6-month results from the INFUSE study at the American Academy of Neurology (AAN) 2026 Annual Meeting, underscoring the importance of evaluating the…
Definium Therapeutics Supports White House Order to Advance Psychedelic Mental Health Treatments Definium Therapeutics a late-stage clinical biopharmaceutical company focused on addressing the root causes of psychiatric and neurological disorders, has publicly expressed its support for a newly signed White…
Inocras & Broad Institute Unveil New TCGA Whole-Genome Insights to Advance Cancer Genomics Researchers from Inocras and the Broad Institute of MIT and Harvard are set to unveil significant new findings from one of the most extensive whole-genome cancer analyses…
Compass Pathways Backs White House Initiative to Accelerate Psychedelic Treatments for Mental Health Compass Pathways plc a biotechnology company focused on expanding access to evidence-based mental health innovations, has expressed strong support for a recent White House Executive Order aimed…
HSS Research Highlights AI’s Growing Role in Predicting Pain Risk and Improving Anesthesia Education At the American Society of Regional Anesthesia and Acute Pain Medicine (ASRA) annual meeting, researchers from Hospital for Special Surgery (HSS) unveiled new findings demonstrating how…
Zai Lab Showcases ZL-1503’s Rapid Itch Relief and Anti-Inflammatory Effects in Atopic Diseases Zai Lab Limited has unveiled new preclinical findings highlighting the therapeutic promise of ZL-1503, an investigational bispecific antibody designed to simultaneously target IL-13 and IL-31Rα pathways. The…
My Mountain Mover Expands Into Dental Industry With Specialized Virtual Assistant Training Program My Mountain Mover (MMM), a recognized leader in providing Medical Virtual Assistants to healthcare practices across the United States, has announced its official expansion into the dental…
Soley Therapeutics Unveils Preclinical AACR 2026 Data Highlighting Selective Anti-Tumor Activity of First-in-Class CKAP2 Modulator STX-6398 Soley Therapeutics, a biotechnology company focused on developing innovative therapies rooted in integrated cell stress biology, has announced the presentation of new preclinical findings…
Orum Therapeutics Unveils AACR 2026 Preclinical Data on ORM-1153 Showing Broad AML Activity and Improved Safety Potential Orum Therapeutics has unveiled new preclinical findings for its investigational therapy ORM-1153, highlighting its potential as a next-generation treatment for acute myeloid leukemia…
SingleCell Biotechnology Unveils High-Throughput Single-Cell Assay Linking Clonal Growth to Molecular Profiles at AACR Single-cell analysis is rapidly reshaping how researchers understand cancer, particularly in the context of tumor heterogeneity and treatment resistance. At the American Association for Cancer Research…
AOP Health US Secures FDA Approval for RAPIBLYK® (Landiolol) in Pediatric SVT Patients AOP Health US, LLC has announced a major regulatory milestone with the U.S. Food and Drug Administration (FDA) approving RAPIBLYK® (landiolol) for the treatment of pediatric patients…
City of Champions Golf Tournament Approaches $1 Million for Prostate Cancer Research The fourth annual City of Champions Golf Tournament, led by Paul M. Wilson, CEO of NetReputation.com, and co-host Michael Muldowney, is approaching a significant milestone in its mission…